• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SANA

SANA

Sana Biotechnology, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.12

-0.12 (-3.70%)

Rating:D+

Company Profile

CEO

Steven D. Harr

IPO Date

2021-02-04

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.23

Prev. Close

$3.24

Day Low

$3.08

Day High

$3.25

52W Low

$2.26

52W High

$6.55

Market Cap

$0.87B

Volume

2.57M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

34.0%

Avg Negative

1.2%

Avg Neutral

64.9%

News Feed

Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates

GlobeNewsWire·7/14/2021·↑ positive

Sana Biotechnology: Hypoimmune Cell Therapies

Seeking Alpha·6/30/2021·↑ positive

Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates

GlobeNewsWire·6/26/2021·↑ positive

Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting

GlobeNewsWire·6/14/2021·↑ positive

Sana Biotechnology to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

GlobeNewsWire·6/2/2021·↑ positive

Sana Biotechnology Reports First Quarter 2021 Financial Results and Business Updates

GlobeNewsWire·5/5/2021·↑ positive

Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021

GlobeNewsWire·4/27/2021·↑ positive

Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates

GlobeNewsWire·3/24/2021·↑ positive

FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies

GlobeNewsWire·3/17/2021·↑ positive

Sana Biotechnology: An Ultra-Risky Bet

Seeking Alpha·2/8/2021·↑ positive